PharmaXportsTrusted Medicines. Healthier Tomorrow.
Tier 1 — Highly regulated

Pharma Export to United States from India

The largest single destination market for Indian pharma exports at the industry level, but the most heavily regulated. Finished formulations require an ANDA and a USFDA-inspected manufacturing facility — WHO-GMP alone does not qualify. This is not a realistic market for a new merchant exporter to enter directly with finished dosage forms; APIs backed by a US DMF are the more realistic near-term route.

Countries: United States

What Sells in This Market

APIs with US DMFGenerics and injectables (via an ANDA-holding manufacturing partner)

Regulatory Pathway

Pathway

ANDA (Abbreviated New Drug Application) for finished formulations; a US Drug Master File (DMF) for APIs.

Plant Requirement

USFDA-inspected facility. WHO-GMP alone is not sufficient.

Timeline

2–4 years per product from dossier start

Barrier to Entry

Very high

Regulatory Considerations

  • Direct-to-consumer prescription medicine export into the US is illegal and has produced criminal convictions of India-based operators — this is a B2B-institutional-only market, and this site is not a consumer pharmacy
  • Not realistic for a new exporter to enter directly in year one; the honest route is API supply with a US DMF, or a distribution relationship with an already ANDA-approved manufacturer
  • Sildenafil, tadalafil and similar molecules are notorious counterfeit-and-spam categories — B2C shipment attracts customs and payment-processor scrutiny even where the generic is legitimately registered

Documentation

  • Commercial invoice
  • Packing list
  • Certificate of Analysis
  • US DMF reference (API)
  • USFDA facility registration

Market Opportunity

We support US-market buyers primarily through API supply backed by a US DMF. We do not claim ANDA-backed finished-formulation supply capability we do not hold, and we do not sell prescription medicines to individual consumers under any circumstances.

Frequently Asked Questions

No. Direct-to-consumer prescription medicine export into the US is illegal regardless of prescription status, and we operate strictly as a B2B platform serving licensed importers, manufacturers and institutional buyers.

Only via a distribution relationship with an already ANDA-approved, USFDA-inspected manufacturing partner — this is not a capability we claim to hold independently as a merchant exporter.

Typical Buyer Types

  • Formulators and manufacturers (API)
  • Distribution partnerships with ANDA-approved manufacturers
Requirements vary by product and destination. This page describes the general market landscape, not company-specific sales coverage or a guarantee of registration outcome.
Request a Quote for United States

Related Products for This Market

Ready to Source for United States?

Get an Export QuoteView Compliance Framework
Get a Quote